Platelet-Rich Plasma (PRP) Therapy is a procedure being investigated for its potential applications in fertility treatment. PRP is prepared using a sample of the patient’s own blood, which is processed to concentrate platelets containing growth factors involved in various biological processes.
In reproductive medicine, PRP has been studied for possible applications involving ovarian function and the uterine lining (endometrium). During preparation, a blood sample is collected and processed to separate platelet-rich plasma from other blood components. Depending on the procedure being investigated, PRP may be administered to the ovaries or uterine cavity using specific clinical techniques. However, its effectiveness in improving fertility outcomes has not been established.
PRP Therapy is not a standard, established fertility treatment. Evidence regarding its benefits, safety, and long-term outcomes remains limited. Patients considering PRP should discuss its investigational status, potential risks, available evidence, and other treatment options with a fertility specialist before making a decision.
PRP Therapy is being investigated for possible applications in reproductive medicine, including:
Women with diminished ovarian reserve
Women with a thin endometrial lining
Patients with poor ovarian response in previous IVF cycles
Patients with recurrent implantation failure
Research involving ovarian function and reproductive health
Selected cases being evaluated within appropriate clinical research settings
PRP is not an established treatment for these conditions. Its effectiveness and safety in fertility care remain uncertain, and it should not be presented as a proven fertility preservation option.
PRP is prepared from the patient’s own blood, although this does not eliminate the possibility of adverse reactions or procedural complications.
Ovarian PRP is being studied for its possible effects on ovarian function, but clinical benefits have not been established.
Intrauterine PRP is being investigated for its possible effects on the endometrial lining, although evidence of improved pregnancy or live birth outcomes remains insufficient.
PRP may be discussed in the context of clinical research and individual fertility assessment, subject to applicable regulatory and ethical requirements.
PRP administration involves blood collection and additional clinical procedures, which may carry risks such as pain, bleeding, infection, or tissue injury.
Platelet-Rich Plasma (PRP) Therapy is a procedure being investigated for potential applications in fertility treatment. PRP is prepared from the patient's own blood and contains concentrated platelets. Its possible effects on ovarian function and the uterine lining are being studied, but improvements in fertility outcomes have not been established.
PRP has been studied in women with diminished ovarian reserve, thin endometrial lining, poor ovarian response, or recurrent implantation failure. However, there is currently insufficient evidence to establish which patients, if any, benefit from PRP in fertility treatment. Its use should be discussed in the context of clinical research and appropriate medical evaluation.
PRP is prepared from the patient's own blood, but this does not make the procedure risk-free. Potential risks include pain, bleeding, infection, and complications related to administration. Evidence regarding the long-term safety of ovarian and intrauterine PRP in fertility treatment remains limited.
No. PRP Therapy does not guarantee pregnancy, and its effectiveness in improving pregnancy or live birth outcomes has not been established. Fertility outcomes depend on several factors, including age, ovarian reserve, embryo development, uterine health, and underlying reproductive conditions.
PRP has been investigated alongside IVF treatment in clinical studies. However, it is not an established component of routine IVF care, and evidence supporting its effectiveness remains insufficient. Patients should discuss the investigational nature, potential risks, and available alternatives with their fertility specialist.
Neelkanth IVF Centre provides fertility consultations and individualized treatment planning based on medical history, diagnostic findings, and clinical requirements. Patients can discuss available fertility treatments, their potential risks and limitations, and the current evidence regarding investigational procedures such as PRP Therapy. Treatment decisions should consider individual medical circumstances and applicable clinical and regulatory requirements.
